For the year ending 2025-12-31, LAB made $85,331K in revenue. -$74,896K in net income. Net profit margin of -87.77%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Total revenue | 85,331 | |||
| Product | 29,553 | |||
| Services And Other Revenue | 13,235 | |||
| Total cost of revenue | 42,788 | |||
| Gross profit | 42,543 | |||
| Research and development | 25,987 | |||
| Selling, general and administrative | 109,861 | |||
| Restructuring and related charges | 14,782 | |||
| Transaction and integration expenses | 2,162 | |||
| Total operating expenses | 152,792 | |||
| Loss from continuing operations | -110,249 | |||
| Interest income | 9,179 | |||
| Interest expense | 26 | |||
| Other income (expense), net | 4,394 | |||
| Loss before income taxes | -96,702 | |||
| Income tax benefit (expense) | -37,876 | |||
| Net loss from continuing operations | -58,826 | |||
| Loss from discontinued operations, net of tax | -16,070 | |||
| Net loss | -74,896 | |||
| Less induced conversion of redeemable preferred stock | 0 | |||
| Net loss attributable to common stockholders | -74,896 | |||
| Basic EPS | -0.2 | |||
| Diluted EPS | -0.2 | |||
| Basic Average Shares | 381,623,000 | |||
| Diluted Average Shares | 381,623,000 | |||
STANDARD BIOTOOLS INC. (LAB)
STANDARD BIOTOOLS INC. (LAB)